Live
- Official: Balakrishna’s ‘Akhanda 2’ locks release date
- Indian Researchers Uncover Key Insights into the Sun's Corona with Aditya-L1
- Brunei sultan urges united efforts from energy companies to face future challenges
- Student Ends Life After Being Scolded by Parents
- Telecom operators geared up to block spammy telemarketer messages from Wednesday
- Mohan Babu should immediately issue a public apology: Press Club President Balavardhan
- Strict Protocols Set for Group 2 Exams in Wanaparthy District
- Delhi Police busts gang involved in cable theft on Delhi Metro Blue Line
- MP's Gita recitation programme finds place in Guinness World Records
- Pawan Kalyan Shines Globally as 2nd Most Googled Actor of 2024 Amid Busy Film, Political Career
Russia to administer new single-dose vaccine
Vaccination drive for overseas job holders
The first batch of the single-dose Sputnik Light vaccine will soon be administered to civilians in Russia, Health Minister Mikhail Murashko said.
Moscow: The first batch of the single-dose Sputnik Light vaccine will soon be administered to civilians in Russia, Health Minister Mikhail Murashko said.
About 2.5 million doses of the vaccine will be ready for use by the end of this month, Xinhua news agency quoted Murashko as saying on Saturday.
He said that the jab will be administered to those who have contracted Covid-19, as well as those who have received two doses of vaccines six months ago or more to boost their immunity.
"It is one-component, it will mainly be used to vaccinate recovered patients and previously vaccinated persons, but we think it will be used for certain categories of citizens as well. It is approved for use only for people under 60," Murashko added.
Russian authorities are encouraging the public to get re-vaccinated to ward off the more dangerous Delta variant, which is spreading rapidly in the country.
Sputnik Light, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology, received authorisation for use in the country in May this year.
It is the first component of Sputnik V, which was registered in August 2020, TASS News Agency reported.
This vector vaccine is based on the human adenovirus, which transmits genetic information of the novel coronavirus.
